Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The technology, developed by Katalin Karikó and Drew Weissman, also holds promise for HIV vaccines and cancer treatment.
The vaccine, dubbed VIR-1388, is designed to stimulate the production of T cells to fight HIV.
U.S. syphilis incidence has increased since 2000, with an escalating toll in medically underserved populations.
Funding includes $1 billion for vaccine trials, $326 million for a new monoclonal antibody and $100 million for novel technologies.
A personalized melanoma vaccine enters a Phase III study, while a pancreatic cancer vaccine moves on to Phase II.
Thermo Fisher Scientific was sued for knowingly profiting from Henrietta Lacks’s extraordinary tissue sample and cell line.
Researchers are working on vaccines that will target multiple flu or coronavirus strains.
Researchers are working on a cure for hepatitis B and a vaccine and long-acting antivirals for hepatitis C.
TB is one of the world’s deadliest diseases and the leading killer of people with HIV.
The experimental vaccine regimen trains the immune system to produce broadly neutralizing antibodies that target HIV.
The Jynneos monkeypox vaccine is highly effective, but two doses are needed for optimal protection.
Experimental flu vaccine, designed to elicit immunity against a broad range of influenza viruses, performed well in a small trial.
Moderna and Merck’s personalized neoantigen vaccine plus checkpoint inhibitor lowered the risk of disease progression after surgery by 44%.
Researchers are exploring novel strategies to help the immune system produce broadly neutralizing antibodies.
Worldwide, TB is one of the leading causes of death for people with HIV.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.